EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species

Karolina M Czajka, Krishnan Venkataraman, Danielle Brabant-Kirwan iD, Stacey A Santi, Chris Verschoor, Vasu D Appanna, Ravi Singh, Deborah P Saunders, Sujeenthar Tharmalingam

Cells · 19.11.2023 · 12 (22) · 2655

DOI: 10.3390/cells12222655 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 19.11.2023. Verfasst von Karolina M Czajka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Sciences Division, NOSM University, 935 Ramsey Lake Rd., Sudbury, ON P3E 2C6, Canada. Hauptthemen laut MEDLINE: Antifungal Agents, Candida. Die Arbeit wurde bisher 190-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Ontario Academic Medicine Association (NOAMA) AFP Innovation Fund, Northern Ontario School of Medicine University (NOSM U) Faculty Association Research Development Award, Northern Ontario Heritage Fund Corporation (NOHFC) Internship Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candidiasis is a highly pervasive infection posing major health risks, especially for immunocompromised populations. Pathogenic Candida species have evolved intrinsic and acquired resistance to a variety of antifungal medications. The primary goal of this literature review is to summarize the molecular mechanisms associated with antifungal resistance in Candida species. Resistance can be conferred via gain-of-function mutations in target pathway genes or their transcriptional regulators. Therefore, an overview of the known gene mutations is presented for the following antifungals: azoles (fluconazole, voriconazole, posaconazole and itraconazole), echinocandins (caspofungin, anidulafungin and micafungin), polyenes (amphotericin B and nystatin) and 5-fluorocytosine (5-FC). The following mutation hot spots were identified: (1) ergosterol biosynthesis pathway mutations (ERG11 and UPC2), resulting in azole resistance; (2) overexpression of the efflux pumps, promoting azole resistance (transcription factor genes: tac1 and mrr1; transporter genes: CDR1, CDR2, MDR1, PDR16 and SNQ2); (3) cell wall biosynthesis mutations (FKS1, FKS2 and PDR1), conferring resistance to echinocandins; (4) mutations of nucleic acid synthesis/repair genes (FCY1, FCY2 and FUR1), resulting in 5-FC resistance; and (5) biofilm production, promoting general antifungal resistance. This review also provides a summary of standardized inhibitory breakpoints obtained from international guidelines for prominent Candida species. Notably, N. glabrata, P. kudriavzevii and C. auris demonstrate fluconazole resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandidaFluconazoleEchinocandinsAzoles

Stichwörter der Autor:innen

Candidaantifungalazolescell wallechinocandinsefflux pumpsergosterolfluorouracilfungal infectiongene mutationsminimal inhibitory concentrationmutationspolyenesresistancetransporters

Substanzen

Antifungal AgentsFluconazoleEchinocandinsAzoles

Autor:innen und Institutionen

  • Medical Sciences Division, NOSM University, 935 Ramsey Lake Rd., Sudbury, ON P3E 2C6, Canada.
  • School of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.
  • Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada.

ORCID-Profile: Danielle Brabant-Kirwan

Förderung

  • Northern Ontario Academic Medicine Association (NOAMA) AFP Innovation Fund
  • Northern Ontario School of Medicine University (NOSM U) Faculty Association Research Development Award
  • Northern Ontario Heritage Fund Corporation (NOHFC) Internship Fund
  • Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant
  • Northern Cancer Foundation

Zitieren

APA

Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C., Appanna, V. D., Singh, R., Saunders, D. P., & Tharmalingam, S. (2023). Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species. Cells, 12(22), 2655. https://doi.org/10.3390/cells12222655

Vancouver

Czajka KM, Venkataraman K, Brabant-Kirwan D, Santi SA, Verschoor C, Appanna VD, et al. Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species. Cells. 2023;12(22):2655. doi:10.3390/cells12222655

BibTeX
@article{Czajka2023,
  author = {Czajka, Karolina M and Venkataraman, Krishnan and Brabant-Kirwan, Danielle and Santi, Stacey A and Verschoor, Chris and Appanna, Vasu D and Singh, Ravi and Saunders, Deborah P and Tharmalingam, Sujeenthar},
  title = {Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {22},
  pages = {2655},
  doi = {10.3390/cells12222655}
}
Kostenlos starten →